id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-012037-9kmul7he	Veenis, J. F.	Remote monitoring of chronic heart failure patients: invasive versus non-invasive tools for optimising patient management	2019-11-19		.txt	text/plain	4452	208	39	Recently, the CardioMEMS device (Abbott Inc., Atlanta, GA, USA), an implantable haemodynamic remote monitoring sensor, has shown promising results in preventing HF-related hospitalisations in chronic HF patients hospitalised in the previous year and in New York Heart Association functional class III in the United States. Multiple studies have investigated the remote monitoring abilities of implantable cardioverter defibrillator/cardiac resynchronisation therapy (ICD/CRT) devices in chronic HF patients to improve HF-related hospitalisation rates (Tab. 2). The IN-TIME RCT showed that using the remote monitoring abilities of the ICD and CRT devices leads to a reduction of a combined endpoint of all-cause death, overnight HF-related hospitalisation, change in New York Heart Association (NYHA) class, and change in patient global self-assessment [19] . In this trial, NYHA class III/IV chronic HF patients were included and investigated as to whether remote haemodynamic monitoring using the ePAD could reduce HF-related hospitalisation, emergency or urgent care visits requiring intravenous therapy.	./cache/cord-012037-9kmul7he.txt	./txt/cord-012037-9kmul7he.txt